Published online before print September 17, 2007

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0607376v1 83/3/467    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, P. A. Search for Related Content PubMed PubMed Citation Articles by Ward, P. A.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0607376

Received for publication June 9, 2007.
Revised August 2, 2007.
Accepted for publication August 28, 2007.

Article

Role of the complement in experimental sepsis

Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA

^@ To whom correspondence should be addressed. E-mail: pward{at}umich.edu.

Abstract

At the Trauma, Shock, Inflammation and Sepsis 2007 conference, the roles of complement activation products and relevant receptors were stressed in the setting of experimental sepsis [cecal ligation and puncture (CLP)] in mice and rats. In addition, some limited evidence was presented related to humans with septic shock (requiring vasopressor support). Collectively, the data suggested that events found in CLP also occur in human sepsis. Experimental sepsis (CLP) in rodents is associated with robust complement consumption and appearance of activation products (C3a, C5a) in plasma. During sepsis, there is up-regulation of C5a receptors (C5aR, C5L2) on blood polymorphonuclear neutrophils (PMNs) and in lungs, liver, kidneys, and heart. CLP also leads to dramatic reductions of C5aRs on blood PMNs, the intensity of which correlates with lethality. Interception in vivo of C5a or C5aR dramatically improves survival after CLP, preserves innate immune functions of blood PMNs, and greatly attenuates the intensity of consumptive coagulopathy and activation of the fibrinolytic system after CLP. In humans with septic shock, there is evidence of complement activation products in plasma along with loss of C5aRs on blood PMNs. These data suggest that in septic humans, interception of C5a or C5aR might be clinically efficacious.

Key Words: mediators • 0

This article has been cited by other articles:

				K. T. Lappegard, D. Christiansen, A. Pharo, E. B. Thorgersen, B. C. Hellerud, J. Lindstad, E. W. Nielsen, G. Bergseth, D. Fadnes, T. G. Abrahamsen, et al. Human genetic deficiencies reveal the roles of complement in the inflammatory network: Lessons from nature PNAS, September 15, 2009; 106(37): 15861 - 15866. [Abstract] [Full Text] [PDF]